UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 79.90
+0.10 (0.13%)
May 29, 2026, 1:30 PM CST
UnicoCell Biomed Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -109.59 | -114.84 | -93.07 | -84.11 | -91.16 | -86.37 |
Depreciation & Amortization | 19.35 | 20.26 | 27.25 | 26.18 | 24.09 | 25.53 |
Other Amortization | 0.29 | 0.29 | 0.33 | 0.21 | 0.18 | 0.74 |
Loss (Gain) From Sale of Assets | - | - | - | -4.83 | - | - |
Loss (Gain) From Sale of Investments | 1.4 | 0.67 | 1.79 | - | - | - |
Stock-Based Compensation | 4.85 | 5.12 | 1.39 | 1.82 | 2.96 | 2.26 |
Provision & Write-off of Bad Debts | 0.14 | 0.12 | 0 | 0 | - | - |
Other Operating Activities | -2.15 | 1.29 | -1.25 | -3.42 | -0.07 | 0.29 |
Change in Accounts Receivable | -0.37 | -0.5 | -0.73 | -0.7 | -0.98 | 0.36 |
Change in Inventory | -1.47 | -0.62 | -2.33 | 0.72 | -0.07 | -2.1 |
Change in Accounts Payable | 0.23 | -0.75 | 1.87 | -0.81 | 0.84 | -0.4 |
Change in Unearned Revenue | -1.94 | -5.52 | 6.6 | -1.51 | 1.52 | - |
Change in Other Net Operating Assets | 2.67 | 3.17 | -3.36 | 0.9 | -0.92 | -2.02 |
Operating Cash Flow | -86.58 | -91.31 | -61.52 | -65.55 | -63.6 | -61.71 |
Capital Expenditures | -3.98 | -5.5 | -5.32 | -15.8 | -14.45 | -23.64 |
Sale of Property, Plant & Equipment | - | - | - | 6.16 | - | - |
Sale (Purchase) of Intangibles | -0.23 | -0.23 | -0.38 | -0.18 | -0.16 | -0.36 |
Investment in Securities | -164.8 | -167.9 | -117.35 | -297.14 | -150.08 | -0.08 |
Other Investing Activities | - | 0.14 | 0.71 | -0.24 | -0.3 | 0.27 |
Investing Cash Flow | -169.01 | -173.49 | -122.35 | -307.2 | -164.99 | -23.8 |
Long-Term Debt Repaid | - | -6.22 | -6.09 | -6.04 | -7.82 | -9.37 |
Net Debt Issued (Repaid) | -6.25 | -6.22 | -6.09 | -6.04 | -7.82 | -9.37 |
Issuance of Common Stock | 179.79 | 302.29 | 179.85 | 344.88 | 159.04 | 3.71 |
Other Financing Activities | - | - | -0.22 | 0.17 | 0.15 | - |
Financing Cash Flow | 173.54 | 296.07 | 173.54 | 339.01 | 151.38 | -5.66 |
Net Cash Flow | -82.04 | 31.27 | -10.33 | -33.74 | -77.21 | -91.17 |
Free Cash Flow | -90.56 | -96.81 | -66.84 | -81.35 | -78.05 | -85.34 |
Free Cash Flow Margin | -341.27% | -321.59% | -209.66% | -330.82% | -542.15% | -1043.70% |
Free Cash Flow Per Share | -1.42 | -1.59 | -1.17 | -1.51 | -1.88 | -2.27 |
Cash Interest Paid | 1.31 | 1.34 | 1.46 | 1.45 | 1.26 | 0.66 |
Cash Income Tax Paid | - | 0.23 | 0.72 | 0.24 | 0.02 | 0.04 |
Levered Free Cash Flow | -58.43 | -67.64 | -44.47 | -54.17 | -49.26 | -54.15 |
Unlevered Free Cash Flow | -57.61 | -66.8 | -43.56 | -53.27 | -48.47 | -53.74 |
Change in Working Capital | -0.87 | -4.22 | 2.05 | -1.4 | 0.39 | -4.16 |